Objectives (Educational Content) :
1. Define neurogastroenterology. 2. Identify conditions treated by a neurogastroenterologist. 3. Describe specific motility testing for common gastrointestinal complaints and identify medications and their mechanism of action in treating motility disorders.
Target Audience:
General pediatricians, family physicians, nurse practitioners, physician assistants, social workers, psychologists, and nurses.
Identified Gap:
Neurogastroenterology is a field of gastroenterology that encompasses the control of digestion and GI system with the enteric nervous system and central nervous system. As we are learning more about the neurohormonal axis and its impact on GI pathology, we can identify testing and medications and learn how their mechanism of action can be used to treat motility disorders.
Estimated Time to Complete the Educational Activity:
1 hour(s)
Expiration Date for CE/CME Credit:
12-06-2024
Method of Participation in the Learning Process:
The learner will view the presentation, successfully complete a post-test and complete an activity evaluation.
Evaluation Methods:
All learners must successfully complete a post-test, as well as an activity evaluation, to claim CE/CME credit.
Disclosure:
Shivani R. Gupta, DO, has returned the disclosure form, indicating that the following relevant financial or other relationship with the following commercial interest: Vital Talk All relationships have been mitigated. The planning committee/CME committee members have indicated that they have no financial relationships with any ineligible companies.
Accreditation Statement:
Children’s Hospital Medical Center of Akron is accredited by the Ohio State Medical Association to provide continuing medical education for physicians.
CHMCA designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Bibliography:
Annahazi, Anita and Schemann, Michael. "The enteric nervous system: “A little brain in the gut”" Neuroforum, vol. 26, no. 1, 2020, pp. 31-42. https://doi.org/10.1515/nf-2019-0027
Chadalavada P, Thota PN, Raja S, Sanaka MR. Peroral Endoscopic Myotomy as a Novel Treatment for Achalasia: Patient Selection and Perspectives. Clin Exp Gastroenterol. 2020;13:485-495
https://doi.org/10.2147/CEG.S230436
Faure C, Righini Grunder F. Dysmotility in Esophageal Atresia: Pathophysiology, Characterization, and Treatment. Front Pediatr. 2017 May 31;5:130. doi: 10.3389/fped.2017.00130. PMID: 28620599; PMCID: PMC5450509.
Müller, M. (2015). Impact of high-resolution manometry on achalasia diagnosis and treatment. Annals of Gastroenterology : Quarterly Publication of the Hellenic Society of Gastroenterology, 28, 3 - 9.
While we are ranked among the best children's hospitals in the country, it's our compassionate approach to treatment that makes us truly exceptional. Through a combination of revolutionary treatments and extraordinary patient experiences, our care does more than heal. It brings the entire family together for emotional support and understanding across multiple locations to reach you in the community where you live. Learn more...
By using this site, you consent to our use of cookies. To learn more, read our privacy policy.
